Rimi Izumihara

Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study

H. Miyoshi, T. Atsumi, A. Nakamura, 2022, Journal of diabetes research.

Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation: a family report

T. Atsumi, K. Tanimura, H. Nomoto, 2020, Journal of Bone and Mineral Metabolism.

Improvement of β-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis.

Y. Kurihara, A. Nakamura, H. Kameda, 2024, The Journal of clinical endocrinology and metabolism.